يعرض 1 - 10 نتائج من 130 نتيجة بحث عن '"Dennis PA"', وقت الاستعلام: 0.79s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    مؤتمر

    المساهمون: Department of Medical Oncology, Thoracic Group, Institut Gustave Roussy, Villejuif, France

    العلاقة: https://dx.doi.org/10.1093/annonc/mdz067.002Test; Planchard D, Garassino MC, Paz-Ares L, Faivre-Finn C, Spira A, Gu Y, et al. Prevalence of programmed death ligand-1 (PD-L1) by demographic, disease and sample characteristics in unresectable, stage III NSCLC (PACIFIC). Ann Oncol. 2019;30 Suppl 2:ii32-ii3.; http://hdl.handle.net/10541/622825Test; Annals of Oncology

  5. 5
    مؤتمر

    المساهمون: Thoracic Unit, Fondazione IRMedical Oncology, University Hospital 12 de Octubre, Madrid, Spain

    العلاقة: https://dx.doi.org/10.1093/annonc/mdz094.001Test; Garassino MC, Paz-Ares L, Hui R, Faivre-Finn C, Spira A, Planchard D, et al. Patient-reported outcomes (PROs) with durvalumab by PD-L1 expression in unresectable, stage III NSCLC (PACIFIC). Ann Oncol. 2019;30 Suppl 2:ii78.; http://hdl.handle.net/10541/622822Test; Annals of Oncology

  6. 6
    مؤتمر

    المساهمون: Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangzhou, China

    العلاقة: https://dx.doi.org/10.1093/annonc/mdz438.005Test; Wu YL, Gray JE, Villegas A, Daniel DB, Vicente D, Murakami S, et al. Three-year overall survival update from the PACIFIC trial. Annals of Oncology. 2019;30:ix108-ix9.; http://hdl.handle.net/10541/622698Test; Annals of Oncology

  7. 7
    مؤتمر

    المساهمون: Department of Respiratory Diseases, University Hospitals KU Leuven, Leuven, Belgium

    العلاقة: https://dx.doi.org/10.1093/annonc/mdz259.002Test; Vansteenkiste JF, Naidoo J, Faivre-Finn C, Özgüroğlu M, Villegas A, Daniel D, et al. 1459PD Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC). Annals of Oncology. 2019;30(Supplement_5):592.; http://hdl.handle.net/10541/622593Test; Annals of Oncology

  8. 8
    مؤتمر

    المساهمون: H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

    العلاقة: https://dx.doi.org/10.1200/JCO.2019.37.15_suppl.8526Test; Gray JE, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. Three-year overall survival update from the PACIFIC trial. J Clin Oncol. 2019;37(15).; http://hdl.handle.net/10541/622445Test; Journal of Clinical Oncology

  9. 9
    مؤتمر

    المساهمون: University of Colorado Cancer Center, Aurora, CO

    العلاقة: https://dx.doi.org/10.1016/j.ijrobp.2019.08.034Test; Raben D, Rimner A, Senan S, Broadhurst H, Pellas T, Dennis PA, et al. Patterns of disease progression with durvalumab in stage III non-small cell lung cancer (PACIFIC). Int J Radiat Oncol Biol Phys. 2019;105(3):683.; http://hdl.handle.net/10541/622415Test; International Journal of Radiation Oncology Biology Physics

  10. 10
    دورية أكاديمية

    المساهمون: Hospital Universitario 12 de Octubre, Lung Cancer Unit CNIO-H12o, CiberOnc and Universidad Complutense, Madrid, Spain

    العلاقة: https://dx.doi.org/10.1016/j.annonc.2020.03.287Test; Paz-Ares L, Dziadziuszko R, Drilon A, John T, Krebs M, Demetri G, et al. Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors or ROS1-Positive NSCLC with CNS Metastases. Oncology Research and Treatment. 2020;43:235-; http://hdl.handle.net/10541/622912Test; Annals of Oncology